DAVID BAYLINK, M.D.
Osteopathic Medicine at Anderson St, Loma Linda, CA

License number
California G46488
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address 2
11370 Anderson St STE 3150, Loma Linda, CA 92354
56994 File Number, Los Angeles, CA 90074
Phone
(909) 558-2191
(909) 558-3111

Professional information

David Baylink Photo 1

Dr. David Baylink, Loma Linda CA - MD (Doctor of Medicine)

Specialties:
Endocrinology, Diabetes & Metabolism, Geriatric Medicine
Address:
11234 Anderson St STE 1513, Loma Linda 92354
(909) 558-4000 (Phone), (909) 558-2099 (Fax)
LOMA LINDA UNIVERSITY FACULTY MEDICAL OFFICES
11370 St, Loma Linda 92354
(909) 796-4870 (Phone), (909) 835-1758 (Fax)
LOMA LINDA UNIVERSITY
11370 Anderson St STE 3300, Loma Linda 92354
(909) 796-4896 (Phone), (909) 796-4896 (Fax)
Languages:
English
Hospitals:
11234 Anderson St STE 1513, Loma Linda 92354
LOMA LINDA UNIVERSITY
11370 Anderson St STE 3300, Loma Linda 92354
LOMA LINDA UNIVERSITY FACULTY MEDICAL OFFICES
11370 St, Loma Linda 92354
Loma Linda University Medical Center
11234 Anderson St, Loma Linda 92354
Education:
Medical School
Loma Linda University
Graduated: 1957
Brigham and Women's Hospital
Lahey Clinic
Usphs Hospital


David Baylink Photo 2

Professor At Loma Linda University

Position:
Professor at Loma Linda University
Location:
Greater Los Angeles Area
Industry:
Biotechnology
Work:
Loma Linda University - Professor


David J Baylink Photo 3

David J Baylink, Loma Linda CA

Specialties:
Endocrinologist
Address:
11234 Anderson St, Loma Linda, CA 92354
11370 Anderson St, Loma Linda, CA 92354


David Baylink Photo 4

Composition And Methods For Osteogenic Gene Therapy

US Patent:
7816140, Oct 19, 2010
Filed:
Jun 13, 2006
Appl. No.:
11/452873
Inventors:
David J. Baylink - Loma Linda CA, US
Susan L. Hall - San Bernardino CA, US
Shin-Tai Chen - Colton CA, US
Subburaman Mohan - Redlands CA, US
Assignee:
The United States of America as represented by the Department of Veterans Affairs - Washington DC
International Classification:
C12N 5/00, C12N 5/02, C12N 5/10, C12N 15/63
US Classification:
435455, 435372, 435383, 424 937
Abstract:
The present disclosure provides compositions and methods for increasing bone growth and/or enhancing wound healing, for example, fracture repair. The disclosure provides recombinant nucleic acids useful for promoting bone growth. For example, the disclosure provides recombinant nucleic acids that encode a fibroblast growth factor-2 (FGF-2) analog. The disclosure also provides vectors and cells incorporating these nucleic acids, as well as FGF-2 analogs encode by them. The disclosure also provides a mouse system of bone marrow transplantation and methods for producing as well as methods for using the system. Methods for inducing division and/or inducing differentiation of a hematopoietic stem cell are also provided, as are methods for enhancing bone growth and/or wound repair (for example, fracture repair).


David Baylink Photo 5

Compositions And Methods For Osteogenic Gene Therapy

US Patent:
2011000, Jan 6, 2011
Filed:
Sep 10, 2010
Appl. No.:
12/879842
Inventors:
David J. Baylink - Loma Linda CA, US
Susan L. Hall - San Bernardino CA, US
Shin-Tai Chen - Colton CA, US
Subburaman Mohan - Redlands CA, US
International Classification:
A01K 67/00, C12N 5/071, C12N 5/0783, C07H 21/04, C12N 15/00, G01N 33/53
US Classification:
800 3, 435377, 435366, 4353723, 536 2351, 800 21, 800 9
Abstract:
The present disclosure provides compositions and methods for increasing bone growth and/or enhancing wound healing, for example, fracture repair. The disclosure provides recombinant nucleic acids useful for promoting bone growth. For example, the disclosure provides recombinant nucleic acids that encode a fibroblast growth factor-2 (FGF-2) analog. The disclosure also provides vectors and cells incorporating these nucleic acids, as well as FGF-2 analogs encode by them. The disclosure also provides a mouse system of bone marrow transplantation and methods for producing as well as methods for using the system. Methods for inducing division and/or inducing differentiation of a hematopoietic stem cell are also provided, as are methods for enhancing bone growth and/or wound repair (for example, fracture repair).